FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/089402 [Registered on: 24/06/2025] Trial Registered Prospectively
Last Modified On: 23/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Ayurvedic medicine in ADHD in children of age 6 to 12 years 
Scientific Title of Study   Randomized controlled trial to evaluate the efficacy of Dheeradi Ghrita in the management of Attention Deficit Hyperactivity Disorder(ADHD) in children of age group 6 to 12 years 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anjali Pratap Thawrani 
Designation  PG Scholar 
Affiliation  Siddhakala ayurved mahavidyalaya 
Address  OPD number 4, kaumarbhritya department , siddhakala ayurved mahavidyalaya, pimparane road, sangamner,ahmadnagar, maharashtra, India 422605

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  09404563407  
Fax    
Email  anjalithawrani1998@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Rajesh Prabhakar Bholane 
Designation  HOD Kaumarbhritya 
Affiliation  Siddhakala ayurved mahavidyalaya 
Address  Bholane hospital, Tajane mala, New nagar road, Sangamner, Ahmadnagar, Maharashtra, India 422605

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9822334742  
Fax    
Email  drrajeshbholane@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vd Rajesh Prabhakar Bholane 
Designation  HOD Kaumarbhritya 
Affiliation  Siddhakala ayurved mahavidyalaya 
Address  Bholane hospital, Tajane mala, New nagar road, Sangamner, Ahmadnagar, Maharashtra, India 422605

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9822334742  
Fax    
Email  drrajeshbholane@gmail.com  
 
Source of Monetary or Material Support  
Siddhakala ayurved mahavidyalaya, Sangamner , Dist Ahmednagar , state Maharashtra, India, pin code 422605 
 
Primary Sponsor  
Name  Anjali Pratap Thawrani 
Address  Siddhakala Ayurved Mahavidyalaya, Pimparane road, Sangamner khurd, Sangamner, Ahmadnagar, Maharashtra, India 422605 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anjali Pratap Thawrani  Siddhakala Ayurved Mahavidyalaya, Sangamner  Kaumarbhritya OPD, siddhakala ayurved mahavidyalaya, pimparane road, sangamner,ahmadnagar, maharashtra, India 422605
Ahmadnagar
MAHARASHTRA 
09404563407

anjalithawrani1998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Board of Ayurved Research and Statistics Committee of Siddhakala Ayurved Mahavidyalaya, Sangamner  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F909||Attention-deficit hyperactivity disorder, unspecified type. Ayurveda Condition: BALAROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugOther than Classical(1) Medicine Name: Shankhapushpi and jatamansi siddha ghrita, Reference: NA, Route: Oral, Dosage Form: Ghrita, Dose: 4(ml), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: Koshna jala), Additional Information: -
2Intervention ArmDrugOther than Classical(1) Medicine Name: Dheeradi Ghrita, Reference: NA, Route: Oral, Dosage Form: Ghrita, Dose: 4(ml), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: Koshna jala), Additional Information: -
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Age group between 6 to 12 yrs.
Patient irrespective of their gender, religion and socioeconomic status.
Patients having Symptoms of ADHD for at least last 6 months.
Patients that fit in DSM IV criteria for diagnosis.
Children with no other neurological condition like mental retardation, down syndrome, microcephaly, etc. 
 
ExclusionCriteria 
Details  Any serious neurological disease diagnosed earlier like cerebral palsy, mental retardation, microcephaly.
Any kind of systemic disease or chronic systemic disease like nephrotic syndrome, type 1 diabetes melitus.
disobedient parents. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study the effect of Dheeradi Ghrita in ADHD  15 days 
 
Secondary Outcome  
Outcome  TimePoints 
To understand the disease ADHD in detail.
To find out ayurvedic correlation of disease with doshas and dushya.
To understand samprapti of disease.
To find better treatment options for ADHD.
To create awareness of disease ADHD.
 
15 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   09/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomized open labelled controlled clinical trial comparing the safety and efficacy of Dheeradi ghrita 4ml thrice a day  with koshna jala and controlled shankhpushpi and jatamansi siddha ghrita 4ml thrice a day with koshna jala for 45 days in 60 children of age group 6 to 12 yrs with Attention Deficit Hyperactivity Disorder (ADHD) 
Close